NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 46 filers reported holding NABRIVA THERAPEUTICS PLC in Q3 2018. The put-call ratio across all filers is 3.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $7,000 | -70.8% | 12,703 | -32.8% | 0.00% | – |
| Q4 2019 | $24,000 | +33.3% | 18,901 | +144.3% | 0.00% | – |
| Q2 2019 | $18,000 | -56.1% | 7,738 | -54.8% | 0.00% | – |
| Q1 2019 | $41,000 | -50.0% | 17,119 | -44.0% | 0.00% | – |
| Q3 2018 | $82,000 | +310.0% | 30,550 | +419.5% | 0.00% | – |
| Q2 2018 | $20,000 | +1900.0% | 5,881 | +2840.5% | 0.00% | – |
| Q1 2018 | $1,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sterling Investment Advisors, Ltd. | 5,000 | $8,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |